Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ian

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Neuro-Oncology Advances|June 8, 2022
Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory <i>NTRK</i> fusion glioblastomaPatrick T Grogan, Dustin A Deming, Jeffrey Helgager, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 16, 2017
PET/CT imaging of the diapeutic alkylphosphocholine analog <sup>124</sup>I-CLR1404 in high and low-grade brain tumorsLance T Hall, Benjamin Titz, H Ian Robins, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2016
The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cellsPaul A Clark, Jordan T Gaal, Joslyn K Strebe, et al.
Endocrinology, Diabetes & Metabolism Case Reports|August 22, 2015
Stereotactic radiosurgery XX: ocular neuromyotonia in association with gamma knife radiosurgeryW C Candy Sze, Joe McQuillan, P Nicholas Plowman, et al.
Breast Cancer Research and Treatment|April 5, 2008
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular regionGregory M Richards, Wolfgang A Tomé, H Ian Robins, et al.
Physics in Medicine and Biology|July 7, 2017
Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404Abigail E Besemer, Benjamin Titz, Joseph J Grudzinski, et al.
Neuro-Oncology|January 31, 2006
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021H Ian Robins, M Won, Wendy F Seiferheld, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapyJarrod B Adkison, Wolfgang Tomé, Songwon Seo, et al.
Neurosurgery|October 7, 2020
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive GlioblastomaDavid M Peereboom, Xiaobu Ye, Tom Mikkelsen, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium studyMichael D Prados, W K A Yung, Patrick Y Wen, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Neuro-Oncology Advances|June 8, 2022
Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory <i>NTRK</i> fusion glioblastomaPatrick T Grogan, Dustin A Deming, Jeffrey Helgager, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 16, 2017
PET/CT imaging of the diapeutic alkylphosphocholine analog <sup>124</sup>I-CLR1404 in high and low-grade brain tumorsLance T Hall, Benjamin Titz, H Ian Robins, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2016
The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cellsPaul A Clark, Jordan T Gaal, Joslyn K Strebe, et al.
Endocrinology, Diabetes & Metabolism Case Reports|August 22, 2015
Stereotactic radiosurgery XX: ocular neuromyotonia in association with gamma knife radiosurgeryW C Candy Sze, Joe McQuillan, P Nicholas Plowman, et al.
Breast Cancer Research and Treatment|April 5, 2008
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular regionGregory M Richards, Wolfgang A Tomé, H Ian Robins, et al.
Physics in Medicine and Biology|July 7, 2017
Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404Abigail E Besemer, Benjamin Titz, Joseph J Grudzinski, et al.
Neuro-Oncology|January 31, 2006
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021H Ian Robins, M Won, Wendy F Seiferheld, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapyJarrod B Adkison, Wolfgang Tomé, Songwon Seo, et al.
Neurosurgery|October 7, 2020
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive GlioblastomaDavid M Peereboom, Xiaobu Ye, Tom Mikkelsen, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium studyMichael D Prados, W K A Yung, Patrick Y Wen, et al.
Pageof 12